Hunan Province Tumor Hospital
Clinical trials sponsored by Hunan Province Tumor Hospital, explained in plain language.
-
Scientists probe genetic secrets of lung cancer relapse after key drug
Knowledge-focused Recruiting nowThis study examines the genetic changes in early-stage lung cancer that comes back after treatment with the drug osimertinib. Researchers will analyze tumor or blood samples from 60 adults whose cancer has returned. The goal is to better understand why recurrence happens, not to …
Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:24 UTC
-
Morning vs. afternoon: timing could boost lung cancer treatment
Knowledge-focused Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon makes a difference for people with stage II-III lung cancer who are about to have surgery. About 156 participants will receive standard treatment plus immunotherapy at either 8-11 AM or 3-6 PM. The goal…
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:21 UTC